| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2022 ( Subtotal = $0 ) |
| | 2022 | 2019 | ARTERIOCYTE, INC. | 45 SOUTH STREET | HOPKINTON | MA | 01748-2237 | MIDDLESEX | USA | R43GM133224 | Scalable manufacturing of human platelet lysate for next generation cell-based technologies | 000 | 1 | NIH | 11/17/2021 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $224,994 ) |
| | 2019 | 2019 | ARTERIOCYTE, INC. | 45 SOUTH ST STE 2/B | HOPKINTON | MA | 01748-2237 | MIDDLESEX | USA | R43GM133224 | Scalable manufacturing of human platelet lysate for next generation cell-based technologies | 000 | 1 | NIH | 4/19/2019 | $224,994 |
| | 2019 | 2017 | ARTERIOCYTE, INC. | 45 SOUTH ST STE 2/B | HOPKINTON | MA | 01748-2237 | MIDDLESEX | USA | R44AR066427 | Biomaterial augmented microfracture repair of full-thickness chondral defects04 | 000 | 4 | NIH | 11/20/2018 | $0 |
| | 2019 | 2017 | ARTERIOCYTE, INC. | 45 SOUTH ST STE 2/B | HOPKINTON | MA | 01748-2237 | MIDDLESEX | USA | R44AR066427 | Biomaterial augmented microfracture repair of full-thickness chondral defects04 | 001 | 4 | NIH | 5/15/2019 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $810,417 ) |
| | 2017 | 2017 | ARTERIOCYTE, INC. | 7100 EUCLID AVE STE 150 | CLEVELAND | OH | 44103-4043 | CUYAHOGA | USA | R44AR066427 | Biomaterial augmented microfracture repair of full-thickness chondral defects04 | 002 | 4 | NIH | 8/4/2017 | $302,276 |
| | 2017 | 2016 | ARTERIOCYTE, INC. | 7100 EUCLID AVE STE 150 | CLEVELAND | OH | 44103-4043 | CUYAHOGA | USA | R44AR066427 | Biomaterial augmented microfracture repair of full-thickness chondral defects04 | 001 | 3 | NIH | 3/3/2017 | $508,141 |
|
| Issue Date FY: 2012 ( Subtotal = $283,861 ) |
| | 2012 | 2012 | ARTERIOCYTE INC | 11000 CEDAR AVENUE | CLEVELAND | OH | 44106-3079 | CUYAHOGA | USA | R43HL110725 | HEMATOPOIETIC RECONSTITUTION USING EX VIVO EXPANDED CORD BLOOD CD34+ CELLS | 000 | 1 | NIH | 7/20/2012 | $283,861 |
| | 2012 | 2011 | ARTERIOCYTE INC | 11000 CEDAR AVENUE | CLEVELAND | OH | 44106 | CUYAHOGA | USA | R43AI092989 | RAPID, HIGH VOLUME PRODUCTION OF RETICULOCYTES FOR P. VIVAX MALARIA RESEARCH | 000 | 1 | NIH | 7/2/2012 | $0 |
| | 2012 | 2010 | ARTERIOCYTE INC | 11000 CEDAR AVENUE | CLEVELAND | OH | 44106 | CUYAHOGA | USA | R43CA156921 | A NOVEL EXPANSION OF PRIMARY LEUKEMIA STEM CELLS | 000 | 1 | NIH | 7/12/2012 | $0 |
|
| Issue Date FY: 2011 ( Subtotal = $806,828 ) |
| | 2011 | 2011 | ARTERIOCYTE INC | 11000 CEDAR AVENUE | CLEVELAND | OH | 44106-3079 | CUYAHOGA | USA | R44HL092706 | THERAPEUTIC POTENTIAL OF EX VIVO EXPANDED HUMAN CORD BLOOD DERIVED CD133+ CELLS I | 000 | 3 | NIH | 3/14/2011 | $586,833 |
| | 2011 | 2011 | ARTERIOCYTE INC | 11000 CEDAR AVENUE | CLEVELAND | OH | 44106-3079 | CUYAHOGA | USA | R43AI092989 | RAPID, HIGH VOLUME PRODUCTION OF RETICULOCYTES FOR P. VIVAX MALARIA RESEARCH | 000 | 1 | NIH | 12/8/2010 | $219,995 |
|
| Issue Date FY: 2010 ( Subtotal = $1,914,324 ) |
| | 2010 | 2010 | ARTERIOCYTE INC | 11000 CEDAR AVENUE | CLEVELAND | OH | 44106-3079 | CUYAHOGA | USA | R43CA156921 | A NOVEL EXPANSION OF PRIMARY LEUKEMIA STEM CELLS | 000 | 1 | NIH | 9/27/2010 | $304,943 |
| | 2010 | 2010 | ARTERIOCYTE INC | 11000 CEDAR AVENUE | CLEVELAND | OH | 44106-3079 | CUYAHOGA | USA | R44HL092706 | THERAPEUTIC POTENTIAL OF EX VIVO EXPANDED HUMAN CORD BLOOD DERIVED CD133+ CELLS I | 000 | 2 | NIH | 3/24/2010 | $1,609,381 |
|
| Issue Date FY: 2008 ( Subtotal = $281,794 ) |
| | 2008 | 2008 | ARTERIOCYTE INC | 11000 CEDAR AVENUE | CLEVELAND | OH | 44106 | CUYAHOGA | USA | R44HL092706 | THERAPEUTIC POTENTIAL OF EX VIVO EXPANDED HUMAN CORD BLOOD DERIVED CD133+ CELLS I | 000 | 1 | NIH | 9/19/2008 | $281,794 |
|
| Issue Date FY: 2007 ( Subtotal = $348,147 ) |
| | 2007 | 2007 | ARTERIOCYTE INC | 11000 CEDAR AVENUE | CLEVELAND | OH | 44106 | CUYAHOGA | USA | R41EY018784 | CAN CD 133 CELLS PREVENT HYPOXIA DRIVEN RETINAL NEOVASCULARISATION IN A RODENT MO | 000 | 1 | NIH | 9/28/2007 | $310,645 |
| | 2007 | 2007 | ARTERIOCYTE INC | 11000 CEDAR AVENUE | CLEVELAND | OH | 44106 | CUYAHOGA | USA | R42HL080856 | MARROW-DERIVED STEM CELLS FOR CORONARY ARTERY ISCHEMIA | 001 | 2 | NIH | 5/14/2007 | $37,502 |
|
| Issue Date FY: 2006 ( Subtotal = $1,229,607 ) |
| | 2006 | 2006 | ARTERIOCYTE INC | 11000 CEDAR AVENUE | CLEVELAND | OH | 44106 | CUYAHOGA | USA | R42HL080856 | MARROW-DERIVED STEM CELLS FOR CORONARY ARTERY ISCHEMIA | 000 | 2 | NIH | 12/7/2005 | $1,229,607 |
|
| Issue Date FY: 2005 ( Subtotal = $142,954 ) |
| | 2005 | 2005 | ARTERIOCYTE INC | 11000 CEDAR AVENUE | CLEVELAND | OH | 44106 | CUYAHOGA | USA | R42HL080856 | MARROW-DERIVED STEM CELLS FOR CORONARY ARTERY ISCHEMIA | 000 | 1 | NIH | 4/21/2005 | $142,954 |
|
|
